Menu
Log In Sign Up
Article

peptide cabergoline is a tablet treatment used to reduce the production of a hormone called prolactin

Published October Oct 17, 2026 6:22 PM

In the specialized field of biochemical research, investigators often explore compounds that interact with th Cabergoline: MedlinePlus Drug Information e endocrine system to better understan Bergolac stimulates libido, lactation suppression (in women), experience multiple ejaculatory orgasms (in men). Guaranteed delivery to EU, UK, US & AU. d hormonal regulation. Among these, peptide cabergoline—frequently categorized as an ergot-derived dopamine receptor agonist—has garnered significant interest. As an enthusiast of high-purity research chemical compounds, I have found that examining the mechanism of action of such substances provides deep insights into how they function as a potent dopamine receptor and a pituitary gland inhibitor.

The Biochemical Profile of Cabergoline

From a structural and pharmacological perspective, cabergoline (often referenced by its chemical identifier, FCE 21336, or CAS Number: 81409-90-7) is a selective D2-like dopamine receptor agonist. Research indicates that it possesses a high affinity for D2, D3, and 5-HT2B receptors. When evaluating high-purity cabergoline samples, verified through NMR and HPLC testing, it is clear why this compound is considered a long-acting dopamine agonist and prolactin inhibitor.

For those studying hormone regulation, it is essential to note that Cabergoline is a dopamine receptor agonist that works by preventing prolactin from being released by the pituitary gland. This specific interaction is why it is frequently studied in the context of hyperprolactinemic disorders.

Re Cabergoline - Dopamine Receptor search Considerations and Observations

When sourcing these materials for laboratory us Cabergoline: Uses, Interactions, Mechanism of Action e, quality and purity are paramount. Whether you are working with a Cabergoline Tablet 0.5 mg or a synthetic liquid, the consistency of the compound is critical for reliable data. In my own review of various research-grade sources, I have obse Cabergoline rved that:

* Cabergoline decreases the production of prolactin, which is a hormone responsible for several physiological functions.

* The compound, often sold under the brand name Dostinex, is a stable ergot derivative.

* Cabergoline is an ergot derived-dopamine D2-like receptor agonist that requires careful handling and storage to maintain its integrity.

Navigating Research Intent

It is important to understand the scope of this compound's utility. Researchers often investigate how Cabergoline (Dostinex) treats high levels of prolactin in co Cabergoline ntrolled settings. In some academic literature, DOSTINEX is indicated for the treatment of dysfunctions related to hyperprolactinemia, including conditions like amenorrhea or galactorrhea. Furthermore, it can be used to treat certain menstrual problems, fertility problems in men and women in specific clinical scenarios, though my focus remains strictly on the biochemical research aspect.

Because Cabergoline is a long-acting dopamine receptor agonist, researchers must be cautious. As some practitioners note, it is not a benign drug. The potency of the substance means that even at low concentrations, it exerts a powerful effect on the D2 receptors. Whether one is utilizing the tablets or a liquid formulation, understanding the pharmacokinetics is vital.

Practical Insights for Researchers

In my experience, when analyzing the literature, one finds that Cabergoline (CAB) has been studied for decades. Since it was first discovered in 1981, it has remained a staple in endocrine research. While some sources suggest a recommended therapeutic dose: 2-3 mg daily in specific therapeutic pat Cabergoline Safety for Lactation Suppression - IABLE hways, research applications usually involve much smaller, specialized quantities.

When conducting your own inquiries, always remember:

1. High-purity Cabergoline is essential for minimizing experimental variables.

2. Cabergoline is a tablet treatment used to reduce the production of a hormone called prolactin by the pituitary gland, a process that is highly sensitive to dosing.

3. Indicated for hyperprolactinemic disorders of either idiopathic or pituitary adenoma origin, the compound’s primary mechanism is its ability to modulate the dopamine pathway.

By maintaining a rigorous standard for purity and understanding the complex receptor affinity of this ergot derivative, those in the research community can continue to map the intricate feedback loops of the endocrine system. Always ensure your s 11 Jun 2023—Cabergoline is a dopamine receptor agonist. The medication is prescribed to treat high levels of the hormone prolactin (a condition known as Read more ources provide comprehensive documentation, such as certificates of analysis, to confirm the identity and quality of the CABERGOLINE you are integrating into your studies.

Leave a Comment
Get new articles in your inbox

News, updates and freebies. No spam, unsubscribe anytime.